X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ORCHID PHARMA LTD - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH ORCHID PHARMA LTD STERLING BIOTECH/
ORCHID PHARMA LTD
 
P/E (TTM) x -1.8 -0.7 - View Chart
P/BV x 0.1 0.5 12.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   ORCHID PHARMA LTD
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ORCHID PHARMA LTD
Sep-13
STERLING BIOTECH/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs11194 5.4%   
Low Rs335 9.7%   
Sales per share (Unadj.) Rs26.8276.5 9.7%  
Earnings per share (Unadj.) Rs-15.0-79.2 18.9%  
Cash flow per share (Unadj.) Rs-5.5-43.5 12.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.953.9 101.8%  
Shares outstanding (eoy) m267.8770.45 380.2%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.30.4 62.6%   
Avg P/E ratio x-0.5-1.4 32.1%  
P/CF ratio (eoy) x-1.3-2.6 48.3%  
Price / Book Value ratio x0.12.1 6.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8628,067 23.1%   
No. of employees `0001.42.8 48.4%   
Total wages/salary Rs m5472,527 21.6%   
Avg. sales/employee Rs Th5,303.36,956.1 76.2%   
Avg. wages/employee Rs Th403.8902.5 44.7%   
Avg. net profit/employee Rs Th-2,959.0-1,993.0 148.5%   
INCOME DATA
Net Sales Rs m7,18119,477 36.9%  
Other income Rs m43407 10.5%   
Total revenues Rs m7,22319,884 36.3%   
Gross profit Rs m9471,103 85.9%  
Depreciation Rs m2,5432,519 101.0%   
Interest Rs m4,3775,227 83.7%   
Profit before tax Rs m-5,931-6,236 95.1%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m-1,924-125 1,537.0%   
Profit after tax Rs m-4,007-5,580 71.8%  
Gross profit margin %13.25.7 232.9%  
Effective tax rate %32.42.0 1,616.1%   
Net profit margin %-55.8-28.7 194.7%  
BALANCE SHEET DATA
Current assets Rs m14,33511,014 130.1%   
Current liabilities Rs m49,80932,060 155.4%   
Net working cap to sales %-494.0-108.1 457.2%  
Current ratio x0.30.3 83.8%  
Inventory Days Days40395 425.2%  
Debtors Days Days17134 508.5%  
Net fixed assets Rs m55,43229,440 188.3%   
Share capital Rs m268705 38.0%   
"Free" reserves Rs m13,9352,043 682.2%   
Net worth Rs m14,7013,800 386.9%   
Long term debt Rs m9,4789,018 105.1%   
Total assets Rs m73,98846,510 159.1%  
Interest coverage x-0.4-0.2 183.8%   
Debt to equity ratio x0.62.4 27.2%  
Sales to assets ratio x0.10.4 23.2%   
Return on assets %0.5-0.8 -65.9%  
Return on equity %-27.3-146.9 18.6%  
Return on capital %-6.4-3.7 172.1%  
Exports to sales %25.937.9 68.4%   
Imports to sales %0.222.6 0.8%   
Exports (fob) Rs m1,8607,378 25.2%   
Imports (cif) Rs m124,406 0.3%   
Fx inflow Rs m1,8607,513 24.8%   
Fx outflow Rs m255,649 0.4%   
Net fx Rs m1,8351,865 98.4%   
CASH FLOW
From Operations Rs m1,7191,682 102.2%  
From Investments Rs m-3,148-9,860 31.9%  
From Financial Activity Rs m1,4266,644 21.5%  
Net Cashflow Rs m-3-1,535 0.2%  

Share Holding

Indian Promoters % 33.9 32.3 105.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.6 -  
FIIs % 9.9 3.3 300.0%  
ADR/GDR % 16.9 4.6 367.4%  
Free float % 39.3 55.3 71.1%  
Shareholders   21,482 84,811 25.3%  
Pledged promoter(s) holding % 55.9 54.9 101.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   PLETHICO PHARMA  BIOCON LTD  FULFORD INDIA  ALKEM LABORATORIES  AJANTA PHARMA  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 22, 2017 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS